Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus

Shusuke Yagi(Shikoku Central Hospital of the Mutual Aid Association of Public School Teachers), Masataka Sata(Tokushima University), Kenya Kusunose(University of the Ryukyus), Ken‐ichi Aihara(Tokushima University), Takayuki Ise(Tokushima University Hospital), Yuriko Takagawa(Tokushima University), Saori Hama(Tokushima University), Daiju Fukuda(Osaka City University), Hotimah Masdan Salim(University of Surabaya), Gulinu Maimaituxun(Tokushima University), Takeshi Soeki(Tokushima University), Michio Shimabukuro(Fukushima Medical University), Koji Yamaguchi(University of Occupational and Environmental Health Japan), Susumu Nishio(Tokushima University Hospital), Hirotsugu Yamada(Tokushima University Hospital), Masashi Akaike(Tokushima University), Tetsuzo Wakatsuki(Tokushima University), Takeshi Tobiume(Tokushima University), Yukina Hirata(Tokushima University Hospital), Tomomi Matsuura(Keio University)
Diabetology & Metabolic Syndrome
October 4, 2017
Cited by 187


Related Papers